Clinical Trial Update: Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating rituximab monotherapy for new-onset nephrotic syndrome in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome in Children

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Nephrotic Syndrome in Children, Rituximab | Phase 3 | Status: RECRUITING